Dadachova E, Revskaya E, Sesay MA, et al. Melanin-binding antibody radiolabeled with therapeutic radionuclide Re188 pre-clinical in vitro and in vivo development for Phase I clinical trial in patients with metastatic melanoma. Proceedings of the 6th International Symposium on the Targeted Anticancer Therapies. Bethesda, MD, USA, March 20-22,2008.
Revskaya E, Dadachova E, Sesay SA, et al. Pre-clinical development of a melanin-binding IgM antibody labeled with Re188 for Phase I clinical trial in patients with metastatic melanoma pigment. Cell Res. 2007; 20(6): 520-521.